<div id="readability-page-1"><p><span>908 Devices (NASDAQ:MASS - Get Free Report)</span> was upgraded by Wall Street Zen from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report issued on Saturday.</p><p>Separately, Weiss Ratings  reissued a &#34;sell (d-)&#34; rating on shares of 908 Devices in a report on Wednesday, January 21st. One equities research analyst  has rated the stock with a Buy rating and one  has given a Sell rating to the company. According to data from MarketBeat, the company  has an average rating of &#34;Hold&#34; and a consensus price target of $12.00.</p><p><b>View Our Latest Stock Report on 908 Devices</b></p><h2>908 Devices Price Performance</h2><p>MASS opened at $6.07 on Friday. The company has a 50 day simple moving average of $6.32 and a two-hundred day simple moving average of $6.64. The firm has a market cap of $226.90 million, a P/E ratio of 11.04 and a beta of 0.47. 908 Devices has a 1-year low of $3.55 and a 1-year high of $9.34. </p><p>908 Devices (NASDAQ:MASS - Get Free Report) last announced its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.01. 908 Devices had a net margin of 34.68% and a negative return on equity of 14.99%. The firm had revenue of $17.38 million for the quarter, compared to the consensus estimate of $16.19 million.  Equities analysts anticipate that  908 Devices will post -1.99 earnings per share for the current year. </p><h2>Insider Activity</h2><p>In other news, CFO Joseph H. Iv Griffith sold 23,175 shares of the business's stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $6.18, for a total value of $143,221.50. Following the transaction, the chief financial officer owned 139,896 shares of the company's stock, valued at approximately $864,557.28. The trade was a 14.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. 23.70% of the stock is currently owned by insiders. </p><h2>Hedge Funds Weigh In On 908 Devices</h2><p>Several institutional investors have recently bought and sold shares of the stock. First Light Asset Management LLC lifted its stake in  908 Devices by 92.6% in the 4th quarter. First Light Asset Management LLC now owns 4,836,186 shares of the company's stock worth $25,390,000 after purchasing an additional 2,325,690 shares in the last quarter.  GM Advisory Group LLC purchased a new position in shares of  908 Devices during the second quarter valued at about $8,309,000.  Needham Investment Management LLC increased its holdings in shares of  908 Devices by 246.8% in the fourth quarter. Needham Investment Management LLC now owns 770,000 shares of the company's stock worth $4,042,000 after purchasing an additional 548,000 shares during the last quarter.  Marshall Wace LLP increased its holdings in shares of  908 Devices by 359.4% in the second quarter. Marshall Wace LLP now owns 648,796 shares of the company's stock worth $4,626,000 after purchasing an additional 507,562 shares during the last quarter.  Finally, First Eagle Investment Management LLC lifted its position in shares of  908 Devices by 125.9% in the third quarter. First Eagle Investment Management LLC now owns 603,962 shares of the company's stock worth $5,291,000 after buying an additional 336,584 shares in the last quarter. 88.06% of the stock is owned by hedge funds and other institutional investors. </p><h2>908 Devices Company Profile</h2> (Get Free Report)<p>908 Devices Inc <span>NASDAQ: MASS<span></span></span> is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company's core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.  </p><p>Key products in 908 Devices' portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than 908 Devices</li><li>A personal warning from Martin Weiss (Please read)</li><li>SpaceX IPO Confirmed: Claim Your Stake Today</li><li>This coin has everything going for it</li><li>Only 500 people today…</li><li>The gold chart Wall Street is terrified of…</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in 908 Devices Right Now?</h2><p>Before you consider 908 Devices, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 908 Devices wasn't on the list.</p><p>While 908 Devices currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

MASS

<p>Wall Street Zen upgraded 908 Devices (NASDAQ:MASS) from a "hold" to a "buy" rating. The company has an average rating of "hold" with a consensus price target of $12.00. 908 Devices reported a quarterly EPS of ($0.05), beating estimates, with revenue of $17.38 million. CFO Joseph H. Iv Griffith sold 23,175 shares recently. Institutional investors hold 88.06% of the stock. 908 Devices specializes in portable analytical instruments for chemical detection.</p>

908 Devices (NASDAQ:MASS) Rating Increased to Buy at Wall Street Zen